4.44
2.30%
0.10
시간 외 거래:
4.41
-0.03
-0.68%
전일 마감가:
$4.34
열려 있는:
$4.32
하루 거래량:
94,836
Relative Volume:
1.02
시가총액:
$37.27M
수익:
$2.74M
순이익/손실:
$-41.38M
주가수익비율:
-0.9427
EPS:
-4.71
순현금흐름:
$-31.10M
1주 성능:
+2.07%
1개월 성능:
+14.73%
6개월 성능:
+58.01%
1년 성능:
+20.00%
Lumos Pharma Inc Stock (LUMO) Company Profile
명칭
Lumos Pharma Inc
전화
512-215-2630
주소
4200 MARATHON BLVD., AUSTIN, TX
Lumos Pharma Inc Stock (LUMO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-03-11 | 업그레이드 | Stifel | Hold → Buy |
2020-12-03 | 개시 | Cantor Fitzgerald | Buy |
2020-08-26 | 개시 | Piper Sandler | Overweight |
2020-08-17 | 재개 | ROTH Capital | Buy |
2020-08-04 | 개시 | H.C. Wainwright | Buy |
Lumos Pharma Inc 주식(LUMO)의 최신 뉴스
Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024 - The Manila Times
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, BMTX, NXU on Behalf of Shareholders - Longview News-Journal
Discover Smart Share Global Among 2 Other Prominent US Penny Stocks - Simply Wall St
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LUMO, ZUO, ARC on Behalf of Shareholders - Stockhouse Publishing
Analyst Expectations For Lumos Pharma's Future - Benzinga
INVESTIGATION ALERT: Halper Sadeh LLC Continues to - GlobeNewswire
Kuehn Law Encourages MMLP, ICCH, FSHP, and LUMO Investors to Contact Law Firm - Morningstar
DPV set to acquire Lumos Pharma for $38m - Pharmaceutical Technology
Lumos Pharma to be acquired by Double Point Ventures - Investing.com Canada
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc. - Marketscreener.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of Shareholders - Longview News-Journal
Jones Trading cuts Lumos Pharma shares rating amid Double Point merger - Investing.com UK
Lumos inks take-private deal with Double Point Ventures - MSN
LUMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Lumos Pharma, Inc. Is Fair to Shareholders - Business Wire
Lumos Pharma Shares Rally After Double Point Deal - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Lumos Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - The Bakersfield Californian
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR) - The Manila Times
Lumos stock in focus after take-private deal (LUMO:NASDAQ) - Seeking Alpha
Double Point to Buy Lumos Pharma for $38M as FDA OKs Lumos Drug Trial - MarketWatch
Hypopituitarism Market Forecasted to Surge in Coming Years, - openPR
Lumos Pharma Inc (LUMO) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Prudence - Investing.com Canada
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors USA
Lumos Pharma maintains target with Buy rating by H.C. Wainwright - Investing.com Canada
Lumos Pharma (NASDAQ:LUMO) Rating Reiterated by HC Wainwright - Defense World
Clene (NASDAQ:CLNN) Stock Quotes, Forecast and News Summary - Benzinga
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024 - ForexTV.com
Apple's iPhone 16 lead times track below past three cycles: MS - Head Topics
You might want to take a look at Lumen Technologies Inc (LUMN) now - SETE News
Stocks of Lexicon Pharmaceuticals Inc (LXRX) are poised to climb above their peers - SETE News
Lumen Technologies (NYSE:LUMN) Trading Down 2.9% - MarketBeat
Caxton Associates LP Increases Stock Holdings in Lululemon Athletica Inc. (NASDAQ:LULU) - Defense World
Lufax Holding Ltd ADR [LU] Revenue clocked in at $3.82 billion, up 83.43% YTD: What’s Next? - The DBT News
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Lululemon Athletica Inc.LULU - PR Newswire
Oct. 7th Deadline Alert: Investors Who Lost More Than $100,000 With Lululemon Athletica Inc. (NASDAQ: LULU) Shares Should Contact the Shareholders Foundation - Newswire
Analytical Overview: Lumen Technologies Inc (LUMN)’s Ratios Tell a Financial Story - The Dwinnex
LB Aluminium's 1Q profit doubles as revenue hits highest in two decades - The Edge Malaysia
Lumen Technologies Inc (NYSE: LUMN) – An Analysis Is What You Need - Stocks Register
Mercer Global Advisors Inc. ADV Has $1.46 Million Stock Holdings in Lululemon Athletica Inc. (NASDAQ:LULU) - Defense World
Sei Investments Co. Sells 41,748 Shares of Lululemon Athletica Inc. (NASDAQ:LULU) - MarketBeat
Lumos awarded national contract with MediGroup for FebriDx - Biotech Dispatch
Lumentum Holdings Inc. (NASDAQ:LITE) Shares Sold by Commonwealth Equity Services LLC - Defense World
Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares - Simply Wall St
Lumos sees respiratory test FebriDx reach wide US audience with MediGroup contract - MSN
Lumen Technologies (NYSE:LUMN) Trading 0.8% Higher - Defense World
Unpacking the Latest Options Trading Trends in Lumen Technologies - Benzinga
What You Didn’t Know About Lululemon Athletica inc. (NASDAQ: LULU) This Week - Stocks Register
Manchester Global Management UK Ltd Has $16.02 Million Stake in Lululemon Athletica Inc. (NASDAQ:LULU) - Defense World
Great Point Partners LLC Purchases New Position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Defense World
Shareholders that lost money on Lululemon Athletica Inc. - GlobeNewswire
Resources Management Corp CT ADV Purchases 746 Shares of Lululemon Athletica Inc. (NASDAQ:LULU) - Defense World
UCB: upbeat after lupus data - Marketscreener.com
Lumos Pharma Inc (LUMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):